Cardamonin inhibits metastasis of Lewis lung carcinoma cells by decreasing mTOR activity

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Niu, Pei Guang ^a   Zhang, Yu Xuan ^a   Shi, Dao Hua ^a   Liu, Ying ^a   Chen, Yao Yao ^a   Deng, Jie ^a  

^a Fujian Provincial Maternity and Child Health Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARDAMONIN; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; S6 KINASE; S6 KINASE 1; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; CHALCONE DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; LEWIS CARCINOMA; LEWIS LUNG CARCINOMA CELL; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSWELL ASSAY; UPREGULATION; WESTERN BLOTTING; WOUND HEALING ASSAY; ANIMAL; CARCINOMA, LEWIS LUNG; CELL MOTION; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; GENE EXPRESSION; GENETICS; LUNG NEOPLASMS; METABOLISM; METASTASIS; PATHOLOGY; PHOSPHORYLATION; SECONDARY; TUMOR CELL LINE;

GASTROPODA; MAMMALIA; MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CADHERINS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHALCONES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENE EXPRESSION; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; PHOSPHORYLATION; TOR SERINE-THREONINE KINASES;

EID: 84930673499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127778     Document Type: Article

References (30)

1. Zhou H, Huang S. Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci 2011; 12(1): 30-42. PMID: 21190521
2. Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 2013; 126(Pt 2): 393-401. doi: 10.1242/jcs.100115 PMID: 23525005
3. Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004; 1014: 155-163. PMID: 15153430
4. Merikallio H, Turpeenniemi-Hujanen T, Paakko P, Makitaro R, Riitta K, Salo S, et al. Snail promotes an invasive phenotype in lung carcinoma. Respir Res 2012; 13: 104-113. doi: 10.1186/1465-9921-13-104 PMID: 23157169
5. Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Hofler H, Becker KF. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer 2008; 98(2): 489-495. PMID: 18026186
6. Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou PG, et al. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene 2013; 32(11): 1351-1362. doi: 10.1038/onc.2012.169 PMID: 22562246
7. Wander SA, Zhao D, Besser AH, Hong F, Wei J, Ince TA, et al. PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy. Breast Cancer Res Treat 2013; 138(2): 369-381. doi: 10.1007/s10549-012-2389-6 PMID: 23430223
8. Zhou H, Huang S. mTOR signaling in cancer cell motility and tumor metastasis. Crit Rev Eukaryot Gene Expr 2010; 20(1): 1-16. PMID: 20528734
9. Lau MT, So WK, Leung PC. Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells. PLoS One 2013; 8(3): e59083. doi: 10.1371/journal.pone.0059083 PMID: 23554977
10. Lau MT, Leung PC. The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells. Cancer Lett 2012; 326(2): 191-198. doi: 10.1016/j.canlet.2012.08.016 PMID: 22922215
11. Pon YL, Zhou HY, Cheung AN, Ngan HY, Wong AS. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res 2008; 68(16): 6524-6532. doi: 10.1158/0008-5472.CAN-07-6302 PMID: 18701475
12. Ekshyyan O, Moore-Medlin TN, Raley MC, Sonavane K, Rong X, Brodt MA, et al. Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models. BMC Cancer 2013; 13: 320-328. doi: 10.1186/1471-2407-13-320 PMID: 23815869
13. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012; 485(7396): 55-61. doi: 10.1038/nature10912 PMID: 22367541
14. Goncalves LM, Valente IM, Rodrigues JA. An overview on cardamonin. J Med Food 2014; 17(6): 633-640. doi: 10.1089/jmf.2013.0061 PMID: 24433078
15. Liao Q, Shi DH, Zheng W, Xu XJ, Yu YH. Antiproliferation of cardamonin is involved in mTOR on aortic smooth muscle cells in high fructose-induced insulin resistance rats. Eur J Pharmacol 2010; 641(2-3): 179-186. doi: 10.1016/j.ejphar.2010.05.025 PMID: 20639142
16. Niu P, Zhang Y, Shi D, Chen Y, Deng J. Cardamonin ameliorates insulin resistance induced by high insulin and high glucose through the mTOR and signal pathway. Planta Med 2013; 79(6): 452-458. doi: 10.1055/s-0032-1328325 PMID: 23512499
17. Tang Y, Fang Q, Shi D, Niu P, Chen Y, Deng J. mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion. Life Sci 2014; 99(1-2): 44-51. doi: 10.1016/j.lfs.2014.01.059 PMID: 24486304
18. Schlosshauer PW, Li W, Lin KT, Chan JL, Wang LH. Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells. Gynecol Oncol 2009; 114(3): 516-522. doi: 10.1016/j.ygyno.2009.06.002 PMID: 19576622
19. Park MK, Jo SH, Lee HJ, Kang JH, Kim YR, Kim HJ, et al. Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells. Life Sci 2013; 92(2): 154-160. doi: 10.1016/j.lfs.2012.11.009 PMID: 23201552
20. Wu MJ, Wen MC, Chiu YT, Chiou YY, Shu KH, Tang MJ. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 2006; 69(11): 2029-2036. PMID: 16732193
21. Lee HB, Ha H. Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis. J Korean Med Sci 2007; 22(6): 943-945. PMID: 18162703
22. Bieri M, Oroszlan M, Zuppinger C, Mohacsi PJ. Biosynthesis and expression of VE-cadherin is regulated by the PI3K/mTOR signaling pathway. Mol Immunol 2009; 46(5): 866-872. doi: 10.1016/j.molimm.2008.09.011 PMID: 18990449
23. Maru S, Ishigaki Y, Shinohara N, Takata T, Tomosugi N, Nonomura K. Inhibition of mTORC2 but not mTORC1 up-regulates E-cadherin expression and inhibits cell motility by blocking HIF-2alpha expression in human renal cell carcinoma. J Urol 2013; 189(5): 1921-1929. doi: 10.1016/j.juro.2012.11.010 PMID: 23147251
24. Kumar M, Allison DF, Baranova NN, Wamsley JJ, Katz AJ, Bekiranov S, et al. NF-kappaB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS One 2013; 8(7): e68597. doi: 10.1371/journal.pone.0068597 PMID: 23935876
25. Lee JH, Jung HS, Giang PM, Jin X, Lee S, Son PT, et al. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. J Pharmacol Exp Ther 2006; 316(1): 271-278. PMID: 16183703
26. Tian SS, Jiang FS, Zhang K, Zhu XX, Jin B, Lu JJ, et al. Flavonoids from the leaves of Carya cathayensis Sarg. inhibit vascular endothelial growth factor-induced angiogenesis. Fitoterapia 2014; 92: 34-40. doi: 10.1016/j.fitote.2013.09.016 PMID: 24096161
27. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8(2): 128-135. PMID: 11821896
28. Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M, Suthanthiran M. Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int 2003; 63(3): 917-926. PMID: 12631072
29. Boffa DJ, Luan F, Thomas D, Yang H, Sharma VK, Lagman M, et al. Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res 2004; 10(1 Pt 1): 293-300. PMID: 14734482
30. El-Naga RN. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis. Toxicol Appl Pharmacol 2014; 274(1): 87-95. doi: 10.1016/j.taap.2013.10.031 PMID: 24211271